VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that the company, its production facilities and medical clinics are all continuing to react to COVID-19 with adjustments to internal business practices consistent with the guidelines of public health authorities. Among other highlights from the update, the company reported that it is encouraging all to suspend travel, work from home when possible, and increase the use of personal protective equipment to lessen the risk of COVID-19 exposure and spread. VIVO Cannabis has also implemented more rigorous cleaning and sanitization practices across all of its sites. At the time of the news release, the company’s production facilities are continuing operations and have no confirmed cases of COVID-19. In addition, has temporarily suspended all in-clinic visits at its Harvest Medicine centers in Calgary, Edmonton, Moncton and Dartmouth and has expanded its telemedicine platform of phone and video consultations, including its HMED Connect App. VIVO Cannabis’ devoted team of clinicians and educators continue to be available and provide support. “As we navigate this ever-evolving situation, we have implemented several measures to protect our employees, while allowing us to continue to operate our business,” VIVO Cannabis CEO Barry Fishman stated in the news release. “We are continuing to monitor the latest developments and the guidance from government bodies and public health authorities. Our commitment to strong corporate governance, sound business judgement and proactive actions are more important now than ever.”
To view the full press release, visit http://ibn.fm/xtPv2
About VIVO Cannabis(TM)
VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VIVOCannabis.com.
NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.